Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia (Q37235598)
Jump to navigation
Jump to search
scientific article published on 18 April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia |
scientific article published on 18 April 2008 |
Statements
1 reference
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia (English)
1 reference
Everett E Vokes
1 reference
Ravi Salgia
1 reference
Halla S Nimeiri
1 reference
Amit M Oza
1 reference
Robert J Morgan
1 reference
Gregory Friberg
1 reference
Kristen Kasza
1 reference
Leonardo Faoro
1 reference
Walter M Stadler
1 reference
Gini F Fleming
1 reference
Chicago Phase II Consortium
1 reference
PMH Phase II Consortium
1 reference
California Phase II Consortium
1 reference
18 April 2008
1 reference
1 reference
49-55
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference